139 related articles for article (PubMed ID: 1536371)
1. Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program.
Havas S; Bishop R; Koumjian L; Reisman J; Wozenski S
Am J Public Health; 1992 Mar; 82(3):458-61. PubMed ID: 1536371
[TBL] [Abstract][Full Text] [Related]
2. Reflotron performance in a community screening program: results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
Havas S; Bishop R; Koumjian L; Reisman J; Wozenski S
Am J Prev Med; 1991; 7(6):397-405. PubMed ID: 1790049
[TBL] [Abstract][Full Text] [Related]
3. The validity of the Reflotron as a screening tool for blood cholesterol.
Al-Humaidi MA; Abolfotouh MA; Sulaiman SA; Al-Kadoumi OF; Khattab MS; Al-Salmi HH; Al-Amari O; Saydain G; Al-Knawy B
J Egypt Public Health Assoc; 1997; 72(1-2):167-87. PubMed ID: 17265630
[TBL] [Abstract][Full Text] [Related]
4. Precision of a dry-chemistry method of lipid screening.
Bowden RG; Kingery PM; Long L
Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol screening: comparative evaluation of on-site and laboratory-based measurements.
Bachorik PS; Rock R; Cloey T; Treciak E; Becker D; Sigmund W
Clin Chem; 1990 Feb; 36(2):255-60. PubMed ID: 2302770
[TBL] [Abstract][Full Text] [Related]
6. In a quasi-simultaneous assessment, imprecise cholesterol monitoring and screening tests were improved.
Costanza MC; Wolff H; James RW; Morabia A
J Clin Epidemiol; 2005 Aug; 58(8):841-8. PubMed ID: 16086475
[TBL] [Abstract][Full Text] [Related]
7. How accurately does the Reflotron dry-chemistry system measure plasma total cholesterol levels when used a community-screening device.
Phillips S; Wyndham L; Shaw J; Walker SF
Med J Aust; 1988 Aug; 149(3):122-5. PubMed ID: 3398798
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of a blood cholesterol measuring instrument used in screening programs.
Lefebvre RC; Lasater TH; McKinlay SM; Gans KM; Walker N; Carleton RA
Public Health Rep; 1989; 104(3):266-70. PubMed ID: 2498976
[TBL] [Abstract][Full Text] [Related]
9. A quality assurance program for the measurement of capillary blood cholesterol levels in private pediatric practices. The Children's Health Project.
Bennett MJ; Tershakovec AM; Cortner JA; Shannon BM
Am J Dis Child; 1993 Mar; 147(3):340-5. PubMed ID: 8438823
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of blood cholesterol, decentralized, using a Reflotron, or centralized in a laboratory. A comparison].
Christensen TE; Agner E; Jensen SE; Jacobsen K; Mahnfeldt MS; Baastrup A
Ugeskr Laeger; 1990 Nov; 152(45):3346-8. PubMed ID: 2238225
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the Reflotron for the determination of plasma cholesterol in capillary blood. Effect of operator variability.
Bhatnagar D; Durrington PN
Occup Med (Lond); 1993 May; 43(2):69-72. PubMed ID: 8495006
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of within-day precision of serum cholesterol measured by a portable analyzer.
Kaminsky LA; Whaley MH
Med Sci Sports Exerc; 1992 Jan; 24(1):134-8. PubMed ID: 1548987
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the accuracy of the Reflotron system in the field.
James R; Tyler C; Henrikson D
Med J Aust; 1988 Aug; 149(3):130-1. PubMed ID: 3398800
[TBL] [Abstract][Full Text] [Related]
14. Measurement issues in cholesterol screening: an overview for nurses.
Finney CP
J Cardiovasc Nurs; 1991 Jan; 5(2):10-22. PubMed ID: 1987330
[TBL] [Abstract][Full Text] [Related]
15. Audit of near patient cholesterol testing in occupational health clinics.
Majeed FA; Turner HJ; Stuart JM; Cooper RD; Laite PA
Occup Med (Lond); 1993 Feb; 43(1):23-6. PubMed ID: 8422442
[TBL] [Abstract][Full Text] [Related]
16. Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group.
Bradford RH; Bachorik PS; Roberts K; Williams OD; Gotto AM
Am J Cardiol; 1990 Jan; 65(1):6-13. PubMed ID: 2294681
[TBL] [Abstract][Full Text] [Related]
17. Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
Havas S; Koumjian L; Reisman J; Hso L; Wozenski S
JAMA; 1991 Jul; 266(3):375-81. PubMed ID: 2056647
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method.
Bachorik PS; Bradford RH; Cole T; Frantz I; Gotto AM; Roberts K; Warnick GR; Williams OD
Clin Chem; 1989 Aug; 35(8):1734-9. PubMed ID: 2758642
[TBL] [Abstract][Full Text] [Related]
19. Total error assessment of five methods for cholesterol screening.
Miller WG; McKenney JM; Conner MR; Chinchilli VM
Clin Chem; 1993 Feb; 39(2):297-304. PubMed ID: 8432020
[TBL] [Abstract][Full Text] [Related]
20. The accuracy of portable cholesterol analyzers in public screening programs.
Naughton MJ; Luepker RV; Strickland D
JAMA; 1990 Mar; 263(9):1213-7. PubMed ID: 2304236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
